April 2020 HSC Section 4 - Plastic and Reconstructive Problems

Waner & O

26. Honig JF, Merten HA. Surgical removal of intra- and extraoral cavernous lym- phangiomas using intraoperative-assisted intralesional fibrin glue injections. J Craniofac Surg 2000;11(1):42–5 . 27. Elluru RG, Balakrishnan K, Padua HM. Lymphatic malformations: diagnosis and management. Semin Pediatr Surg 2014;23(4):178–85 . 28. Perkins JA, Manning SC, Tempero RM, et al. Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg 2010;142(6):795–803, 803.e1 . 29. Swetman GL, Berk DR, Vasanawala SS, et al. Sildenafil for severe lymphatic mal- formations. N Engl J Med 2012;366(4):384–6 . 30. Danial C, Tichy AL, Tariq U, et al. An open-label study to evaluate sildenafil for the treatment of lymphatic malformations. J Am Acad Dermatol 2014;70(6):1050–7 . 31. Koshy JC, Eisemann BS, Agrawal N, et al. Sildenafil for microcystic lymphatic malformations of the head and neck: a prospective study. Int J Pediatr Otorhino- laryngol 2015;79(7):980–2 . 32. Rankin H, Zwicker K, Trenor CC 3rd. Caution is recommended prior to sildenafil use in vascular anomalies. Pediatr Blood Cancer 2015;62(11):2015–7 . 33. Triana P, Dore M, Cerezo VN, et al. Sirolimus in the treatment of vascular anom- alies. Eur J Pediatr Surg 2017;27(1):86–90 . 34. Hartford CM, Ratain MJ. Rapamycin: something old, something new, sometimes borrowed and now renewed. Clin Pharmacol Ther 2007;82(4):381–8 . 35. Alemi AS, Rosbe KW, Chan DK, et al. Airway response to sirolimus therapy for the treatment of complex pediatric lymphatic malformations. Int J Pediatr Otorhinolar- yngol 2015;79(12):2466–9 . 36. Lackner H, Karastaneva A, Schwinger W, et al. Sirolimus for the treatment of chil- dren with various complicated vascular anomalies. Eur J Pediatr 2015;174(12): 1579–84 . 37. Hortlund M, Arroyo Muhr LS, Storm H, et al. Cancer risks after solid organ trans- plantation and after long-term dialysis. Int J Cancer 2017;140(5):1091–101 . 38. Cerrati EW, O TM, Binetter D, et al. Transmucosal bleomycin for tongue lymphatic malformations. Int J Otolaryngol Head Neck Surg 2015;4:81–5 . 39. Kennedy TL, Whitaker M, Pellitteri P, et al. Cystic hygroma/lymphangioma: a rational approach to management. Laryngoscope 2001;111(11 Pt 1):1929–37 . 40. Bloom DC, Perkins JA, Manning SC. Management of lymphatic malformations and macroglossia: results of a national treatment survey. Int J Pediatr Otorhinolar- yngol 2009;73(8):1114–8 . 41. Glade RS, Buckmiller LM. CO 2 laser resurfacing of intraoral lymphatic malforma- tions: a 10-year experience. Int J Pediatr Otorhinolaryngol 2009;73(10):1358–61 . 42. Oomen KP, Paramasivam S, Waner M, et al. Endoscopic transmucosal direct puncture sclerotherapy for management of airway vascular malformations. Laryn- goscope 2016;126(1):205–11 .

235